Funder
Airc Italian Foundation for Cancer Research
FRS-FNRS
Reference52 articles.
1. Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer;Bokemeyer;J. Clin. Oncol.,2009
2. Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study;Douillard;J. Clin. Oncol.,2010
3. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N. Engl. J. Med.,2009
4. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer;Cunningham;N. Engl. J. Med.,2004
5. KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer;De Roock;Lancet Oncol.,2011